Kwality Pharmaceuticals Ltd — Important, 24-07-2026: Company Update

Kwality Pharmaceuticals has achieved a significant milestone in its biologics development, receiving permission from the relevant drug authority to manufacture pilot batches of Pembroluzimab. This approval allows the company to transition the product from the research and development stage to preclinical studies. Kwality Pharma's strategic goal is to be an early generic manufacturer of Pembroluzimab after the reference product's patent expires, subject to successful development and subsequent regulatory clearances. This move positions the company for future market opportunities.